SERA
LIVE

Serial Number

98978823

Owner

Sera Prognostics, Inc.

Attorney

Laura M. Franco

First Use Date

Jul 31, 2025

Filing Date

Dec 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SERA Trademark

Serial Number: 98978823

SERA is a trademark filed by Sera Prognostics, Inc. on December 12, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Sera Prognostics, Inc. (7 trademarks)

2749 E Parleys Way, Suite 200
Salt Lake City, UT 84109

Entity Type: 03

Trademark Details

Filing Date

December 12, 2024

Registration Date

Not Registered

First Use Anywhere

July 31, 2025

First Use in Commerce

July 31, 2025

Published for Opposition

August 26, 2025

Goods & Services

Medical test kits for home use for testing for pregnancy, pregnancy planning, pregnancy tracking and management, and pregnancy-related issues, conditions, features or complications, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; preparations for testing for pregnancy, pregnancy planning, pregnancy tracking and management, and pregnancy-related issues, conditions, features or complications, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; medical test kits for use in a doctor's office for testing for pregnancy, pregnancy planning, pregnancy tracking and management, and pregnancy-related issues, conditions, features or complications, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease

Medical testing services for pregnancy, pregnancy planning, pregnancy tracking and management, and pregnancy-related issues, features, conditions, or complications; medical diagnostic testing services to detect pregnancy and for pregnancy planning, pregnancy tracking and management, and pregnancy-related health issues, features, conditions, or complications, namely preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; providing a website featuring health information about women's health and pregnancy and pregnancy planning, pregnancy tracking and management, pregnancy-related health features, issues, conditions or complications namely preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; providing health information related to pregnancy, pregnancy tracking and management, and pregnancy-related health features, issues, conditions or complications namely preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease via e-mail and online; providing current news, information and commentary in the fields of menstrual cycles, ovulation, fertility, pregnancy, pregnancy planning, pregnancy tracking and management, pregnancy- related health features, issues, conditions or complications, namely preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease, women's body measurements for medical purposes, gynecological, sexual, and emotional health information, and related women's health issues; providing an internet news website portal featuring links to news stories and articles in the field of current events relating to menstrual cycles, ovulation, fertility, pregnancy, pregnancy planning, pregnancy tracking and management, pregnancy-related health issues, conditions, features or complications, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease, women's body measurements, gynecological, sexual, and emotional health information, and related women's health issues; Medical laboratory analysis services relating to pregnancy testing, pregnancy planning, pregnancy tracking and management, and pregnancy-related features, issues, conditions or complications namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; Providing medical diagnostic testing services to detect pregnancy related issues, features, conditions, and complications, including risk of preterm birth, pre-term labor, imminent preterm birth, risk of preeclampsia, imminent preeclampsia, risk of gestational diabetes, gestation diabetes, risk of gestation hypertension, gestational hypertension, risk of fetal growth restriction, fetal growth restriction, risk of post-partum depression, and post-partum depression, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; Providing information on pregnancy and pregnancy related health topics, namely, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; menstrual disorders, infertility, endometriosis, uterine fibroids, polycystic ovary syndrome, sexually transmitted infections, and menopause; Medical testing services; Medical testing services to predict risk of pre-term birth, pre-term labor, preeclampsia, gestational diabetes, gestation hypertension, fetal growth restriction, and post-partum depression, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease.

Educational services, namely, providing a website featuring non-downloadable webcasts, photographs, and audio and video recordings featuring stories and articles in the field of current events relating to menstrual cycles, ovulation, fertility, pregnancy, pregnancy planning, pregnancy tracking and management, pregnancy-related issues, conditions, features, complications, women's body measurements, gynecological, sexual, and emotional health information, and related women's health issues; providing online non-downloadable journals, non-downloadable articles and blogs on topics related to women's health and pregnancy planning, pregnancy tracking and management, and pregnancy-related issues, conditions, features and complications

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Jul 30, 2026 SUPC
DIVISIONAL PROCESSING COMPLETE
Jul 30, 2026 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 1, 2026 AITU
USE AMENDMENT FILED
Apr 10, 2026 IUAF
DIVISIONAL REQUEST RECEIVED
Apr 10, 2026 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Apr 10, 2026 ERTD
TEAS STATEMENT OF USE RECEIVED
Apr 10, 2026 EISU
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 20, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 20, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 20, 2026 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 21, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 26, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 20, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 19, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 18, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 12, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 12, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 12, 2025 CNRT
ASSIGNED TO EXAMINER
May 30, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2025 NWOS
NEW APPLICATION ENTERED
Dec 12, 2024 NWAP